Clinical trial on the efficacy of moxidectin oral gel formulation on donkeys naturally infected by cyathostominae
Donkeys and horses share several parasites including the small strongyles, Cyathostominae. Moxidectin (MOX), a compound of macrocyclic lactones, has a wide range of ecto and endoparasitic activity in many species. For horses, MOX is available as oral gel formulation that provides excellent and long-lasting efficacy against nematodes such as large and small strongyles. There is a paucity of data available on the efficacy of anthelmintics used in donkeys (Veneziano et al., 2011). Therapeutics, such as antiparasitic compounds, are often administered to donkeys on the basis of dosage and intervals recommended for horses, because very few drugs have donkey-specific label indications (Grosenbaugh et al., 2011). The objective of the present study was to evaluate the field efficacy and Egg Reappearance Period (ERP) of MOX oral gel up to 84 days at horse dose against natural infection of Cyathostominae in donkeys.